FAKTOR OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Market Closed - BOERSE MUENCHEN 20:47:16 31/05/2024 BST | ||
| 19.87 EUR | -5.70% |
|
| 1 month | +29.87% | ||
| 3 months | +96.93% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 31/05/24 | 19.87 | -5.70% |
| 30/05/24 | 21.07 | +0.14% |
| 29/05/24 | 21.04 | +0.91% |
| 28/05/24 | 20.85 | +10.49% |
| 27/05/24 | 18.87 | -2.98% |
Real-time BOERSE MUENCHEN
Last update May 31, 2024 at 08:47 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
UniCredit
|
| WKN | HD36D5 |
| ISIN | DE000HD36D52 |
| Date issued | 28/02/2024 |
| Strike | 50.32 $ |
| Maturity | Unlimited |
| Parity | 0.45 : 1 |
| Emission price | 10.43 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 21.88 € |
|---|---|
| Lowest since issue | 7.3 € |
| Spread | 0.03 € |
| Spread % | 0.15% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.09
USD
Average target price
53.19
USD
Spread / Average Target
+29.46%
- Stock Market
- Certificates
- Certificat
